PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy

In this study we set out to investigate whether anti PDL1 or PD–1 treatment targeting the immune system could be used against multiple myeloma. DCs are important in regulating T cell responses against tumors. We therefore determined PDL1 and PDL2 expression on DC populations in bone marrow of patien...

Full description

Bibliographic Details
Main Authors: Sponaas, Anne-Marit, Moharrami, Neda Nejati, Feyzi, Emadoldin, Standal, Therese, Holth Rustad, Even, Waage, Anders, Sundan, Anders
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596870/